Objectives

By attending this workshop, participants should be able to:

• Enhance expertise in low-dose CT lung cancer screening (LDCT LCS) and early-stage non-small cell lung cancer (NSCLC) by engaging with cutting-edge research, best practices, and case studies from international experts.
• Collaborate with leading researchers and patient representatives to develop new clinical research projects and guidelines, addressing critical gaps in thoracic oncology.
• Network with peers, early-career professionals, and research partners to build long-term collaborations, leveraging synergies among international and multidisciplinary initiatives.
• Apply innovative diagnostic and therapeutic strategies discussed during the workshop, including radiomics, biomarkers, and molecular testing, to clinical practice and research.
• Draft publications and proposals for academic journals and grant applications, contributing to the broader dissemination of findings and advancing future thoracic oncology research.
• Integrate patient perspectives into clinical and research approaches to ensure that studies align with patient needs and expectations, enhancing the relevance and impact of future projects.

Diseases/methods

• Thoracic oncology

CME credits

This event has been accredited with 7 CME credits by the European Board for Accreditation in Pneumology (EBAP). The number of credits that you will receive will correspond to the time you spend viewing the sessions live.